Common Questions About Our New Cancer Hospital
Will this change impact inpatient care today?
At this time, hospital admissions for cancer care will continue to occur at BWH. If you need surgery, it will take place at the hospital where your surgeon operates (BWH for BWH surgeons, BIDMC for BIDMC surgeons). Your Dana-Farber care team remains your first point of contact for any questions or concerns about your cancer care.
Dana-Farber understands the importance of the relationships you have with your providers and will always respect patient choice. If you currently see a surgeon, radiation oncologist, or any other specialist at BWH, Dana-Farber will fully support you if you choose to continue with that physician throughout and after the transition.
As we move through this transition, we will keep you informed every step of the way.
Will my care team change?
Your ongoing treatment and access to services and specialists will not be affected. You can continue to see your current doctors and other care providers. If you currently see a surgeon, radiation oncologist, or any other specialist at BWH, Dana-Farber will fully support you if you choose to continue with that physician throughout and after the transition.
Will I be able to stay with my provider?
Dana-Farber understands the importance of the relationships you have with your providers and will always respect patient choice. If you currently see a surgeon, radiation oncologist, or any other specialist at BWH, Dana-Farber will fully support you if you choose to continue with that physician during and after the transition.
In the future collaboration, how will I get information from my care team? How will my care team share information with each other?
While it is several years before our future collaboration goes into effect, we are working now to set up patient-oriented communications and access for all care team members to your latest information. When the future collaboration goes into effect, we will ensure a seamless integration of patient records and a consistent flow of information, for both our patients and your care teams.
Does the future collaboration affect Dana-Farber's regional campuses outside of Boston?
No. Our future collaboration with BIDMC only applies to the Longwood Medical Area and Chestnut Hill locations. There are no planned changes to our regional campuses in Brighton, Weymouth, Foxborough, Milford, Merrimack Valley, or Londonderry.
Will there be any changes to outpatient care at the Yawkey Center or Chestnut Hill?
No. Patients who receive outpatient care at our Yawkey Center or Chestnut Hill locations will continue to do so without interruption.
Will this impact pediatric care?
Our joint program for pediatric cancer care with Boston Children's Hospital will continue without change or interruption.
Where will the new inpatient hospital be located?
The new inpatient hospital will be located at the corner of Brookline Avenue and Joslin Place, across the street from Dana-Farber’s Yawkey Center for Cancer Care (450 Brookline Ave.). It will be a brand-new building adjacent to both Dana-Farber’s and BIDMC’s Longwood campuses.
